Skip to main navigation Skip to search Skip to main content

Toxic myopathies

  • Regenstrief Institute Inc

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

The incidence of toxic myopathies is increasing. This may be in part related to the large number of readily available compounds, including therapeutic drugs, drugs of abuse, and environmental toxins, that are potentially toxic to muscle. Toxic myopathy should be included in the differential diagnosis of anyone exposed to any of the compounds discussed here who develops weakness, wasting, and an elevated CK with or without pain. Specific EMG and muscle biopsy features are seen in many of these conditions and may be extremely helpful in making the diagnosis. Recognition of these myopathies is crucial because most are reversible upon discontinuation of exposure to the toxin.

Original languageEnglish
Pages (from-to)711-730
Number of pages20
JournalNeurologic Clinics
Volume15
Issue number3
DOIs
StatePublished - 1997

Fingerprint

Dive into the research topics of 'Toxic myopathies'. Together they form a unique fingerprint.

Cite this